A tumor necrosis factor-α promoter polymorphism and pregnancy complications: Results of a prospective cohort study in 1652 pregnant women

Reproductive Sciences

Volumn 14, Issue 5, 2007, Pages 425-429

  Stonek, Felix ^a   Bentz, Eva Katrin ^b   Hafner, Erich ^a   Metzenbauer, Martin ^a   Philipp, Karl ^a   Hefler, Lukas A ^b   Tempfer, Clemens B ^b  

^a DANUBE HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Intrauterine fetal death; Preeclampsia; Preterm delivery; Small for gestational age; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; FEMALE; FETUS DEATH; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FOR DATE INFANT; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; GENETIC MARKER; GENETICS; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY;

ADULT; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY COMPLICATIONS; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38449101113     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719107305213     Document Type: Article

References (21)

1. Tempfer CB, Schneeberger C., Huber JC Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics. 2004 ; 5: 57-65.
2. Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med. 1996 ; 334: 1717-1725.
3. Keenan JA, Chen TT, Chadwell NL, Torry DS, Caudle MR IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol. 1995 ; 34: 381-385.
4. Bergqvist A., Bruse C., Carlberg M., Carlstrom K. Interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium. Fertil Steril. 2001 ; 75: 489-495.
5. Teramoto M., Kitawaki J., Koshiba H., et al. Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. Am J Reprod Immunol. 2004 ; 51: 352-357.
6. Wilson AG, di Giovine FS, Blakemore AI, Duff GW Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992 ; 1: 353.
7. D'Alfonso S., Richiardi PM A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics. 1994 ; 39: 150-154.
8. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997 ; 94: 3195-3199.
9. Kaluza W., Reuss E., Grossmann S., et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol. 2000 ; 114: 1180-1183.
10. Kilani RT, Mackova M., Davidge ST, Winkler-Lowen B., Demianczuk N., Guilbert LJ Endogenous tumor necrosis factor alpha mediates enhanced apoptosis of cultured villous trophoblasts from intrauterine growth-restricted placentae. Reproduction. 2007 ; 133 (1). 257-264.
11. Daher S., Fonseca F., Ribeiro OG, Musatti CC, Gerbase-DeLima M. Tumor necrosis factor during pregnancy and at the onset of labor and spontaneous abortion. Eur J Obstet Gynecol Reprod Biol. 1999 ; 83 (1). 77-79.
12. Shaarawy M., Nagui AR Enhanced expression of cytokines may play a fundamental role in the mechanisms of immunologically mediated recurrent spontaneous abortion. Acta Obstet Gynecol Scand. 1997 ; 76: 205-211.
13. Mueller-Eckhardt G., Mallmann P., Neppert J., et al. Immunogenetic and serological investigations in nonpregnant and in pregnant women with a history of recurrent spontaneous abortions. German RSA/IVIG Study Group. J Reprod Immunol. 1994 ; 27: 95-109.
14. America College of Obstetricians and Gynecologists Committee on Practice Bulletins-obstetrics. ACOG practice bulletin no. 33, January 2002. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002 ; 99: 159-167.
15. Hohenauer L. Intrauterine Wachstumskurven für den deutschsprachigen Raum. Zentralblatt Geb Perinatol. 1980 ; 184: 167-179.
16. Fargion S., Valenti L., Dongiovanni P., et al. Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood. 2001 ; 97: 3707-3712.
17. Pietrowski D., Bettendorf H., Keck C., et al. Lack of association of TNFalpha gene polymorphisms and recurrent pregnancy loss in Caucasian women. J Reprod Immunol. 2004 ; 61: 51-58.
18. Wieser F., Fabjani G., Tempfer C., et al. Tumor necrosis factor-alpha promotor polymorphisms and endometriosis. J Soc Gynecol Investig. 2002 ; 9: 313-318.
19. Speer EM, Gentile DA, Zeevi A., Pillage G., Huo D., Skoner DP Role of single nucleotide polymorphisms of cytokine genes in spontaneous preterm delivery. Hum Immunol. 2006 ; 67: 915-923.
20. Roberts AK, Monzon-Bordonaba F., Van Deerlin PG, et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol. 1999 ; 180: 1297-1302.
21. Moore S., Ide M., Randhawa M., Walker JJ, Reid JG, Simpson NA An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. BJOG. 2004 ; 111: 125-132.